Monday, February 26, 2024 6:53:02 PM
Recent HSCS News
- HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG • GlobeNewswire Inc. • 04/24/2024 01:00:00 PM
- HeartSciences to Present at the LD Micro Invitational XIV Conference • GlobeNewswire Inc. • 04/02/2024 08:15:00 PM
- HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients • GlobeNewswire Inc. • 03/26/2024 01:00:00 PM
- HeartSciences Reports Third Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 03/14/2024 08:15:00 PM
- HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology • GlobeNewswire Inc. • 03/06/2024 02:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/05/2024 09:55:25 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2024 10:32:30 PM
- HeartSciences Adds Key Advisor to its Scientific Advisory Board • GlobeNewswire Inc. • 02/26/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:02 PM
- HeartSciences Expands its Scientific Advisory Board • GlobeNewswire Inc. • 02/12/2024 02:00:00 PM
- HeartSciences Appoints New Scientific Advisory Board Member • GlobeNewswire Inc. • 02/01/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 02:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 01:59:38 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/18/2024 01:14:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/18/2024 01:11:17 PM
- HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 12:55:34 PM
- HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting • GlobeNewswire Inc. • 01/03/2024 09:15:00 PM
- HeartSciences Reports Second Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 12/14/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:07:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 09:04:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/13/2023 10:25:54 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/11/2023 01:30:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/08/2023 10:14:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM